Adcock Ingram Leaves Zim Market

South African pharmaceutical group Adcock Ingram has left the Zimbabwean market after selling its operating subsidiary for an undisclosed amount.

Adcock Ingram is listed on the Johannesburg Stock Exchange (JSE). It had interests in Bulawayo-based manufacturer and distributor of pharmaceutical, Datlabs, through a wholly-owned subsidiary, Pharmalabs (Jersey).

A statement on the group’s unaudited interim results for the six months ended December 31, 2018 reads in part as follows:

On 31 January, the group signed a sale of shares agreement, disposing of its interest in Pharmalab (Jersey) Limited, the owner of Datlabs. All conditions precedent were met and the proceeds have been received.

The company produces brands such as cafemol, panado, solphyllex and lanolene milk under licence, among other others.

The decision to exit the Zimbabwean market could be attributable to the serious competition that the company has been facing from imports.

More: Newsday

Join WhatsApp & Telegram News Groups:

WhatsApp Group:

Telegram Group:

Back to top

Write a Comment

Your email address will not be published.

Share Full Post

Nyaradzo logo

RSS Recent Profiles Created